Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Tuesday, 20 September 2022, 23:50 HKT/SGT
Share:
Sirnaomics to Present Latest Developments on siRNA Therapeutics for Cancer and GalAhead(TM) Platform Programs at the 2nd Annual Oligonucleotide Therapeutics and Delivery Conference

Gaithersburg, MD, USA and Suzhou BioBay, China, Sept 20, 2022 - (ACN Newswire) - Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today that it will present the latest developments on delivery of novel RNAi therapies for cancer, and its GalAhead(TM) platform and programs, at the 2nd Annual Oligonucleotide Therapeutics and Delivery Conference. The conference will take place on September 21 and 22, 2022 with workshops on September 20, 2022 at Copthorne Tara Hotel, London, UK.

Presentation Details

Presentation Title: Delivery of Novel siRNA Constructs for Treating Cancer
Presenter: Dr. David Evans, Chief Scientific Officer, Sirnaomics
Time/Date: 15:20 GMT on Wednesday, September 21, 2022
Presentation Topics:
-- Creating novel siRNA constructs for cancer treatment
-- Introduction to Sirnaomics' polypeptide nanoparticle delivery system (PNP-IT)
-- Introduction to STP705, Sirnaomics' lead oncology siRNA therapeutic targeting TGF-beta1/COX-2
-- Discussion of novel siRNA therapeutics targeting other oncology indications

Presentation Title: GalAhead(TM) Therapeutic Platform and Programs
Presenter: Dr. Jack Wei, Senior Director, Sirnaomics
Time/Date: 16:30 GMT on Thursday, September 22, 2022
Presentation Topics:
-- Introduction to GalAhead(TM), Sirnaomics' GalNAc-RNAi therapeutic platform
-- Miniaturized RNAi (mxRNA) as a key technological component of the platform
-- Validation of technology in vivo and in vitro
-- Progress report on GalAhead(TM)-based programs

For more information about Sirnaomics' presentation, please visit the event website at https://www.smgconferences.com/pharmaceuticals/uk/conference/oligonucleotide-discovery-delivery.

About Sirnaomics

Sirnaomics is an RNA therapeutics biopharmaceutical company with product candidates in preclinical and clinical stages that focuses on the discovery and development of innovative drugs for indications with medical needs and large market opportunities. Sirnaomics is the first clinical-stage RNA therapeutics company to have a strong presence in both China and the United States, and also the first company to achieve positive Phase IIa clinical outcomes in oncology for an RNAi therapeutic for its core product, STP705. Learn more at www.sirnaomics.com.

CONTACT:
Investor Relations:
Nigel Yip, MBA
Chief Financial Officer, China, Sirnaomics
Email: NigelYip@sirnaomics.com

US Media Contact:
Alexis Feinberg
Tel: +1 203 939 2225
Email: Alexis.Feinberg@westwicke.com

Asia Media Contact:
Bunny Lee
Tel: +852 3150 6707
Email: sirnaomics.hk@pordahavas.com



Topic: Press release summary Sectors: BioTech, Healthcare & Pharm
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
First three HKTDC trade fairs of 2026 draw some 82,000 international buyers  
Jan 15, 2026 19:46 HKT/SGT
" title="NEC Launches "NEC Composable Disaggregated Infrastructure Solution" for Distributed Computing Resources
"> NEC Launches "NEC Composable Disaggregated Infrastructure Solution" for Distributed Computing Resources
  
Thursday, January 15, 2026 4:00:00 PM
A True Empowerer - AGFA HealthCare Radiates Imaging Innovation at ECR 2026  
Jan 15, 2026 16:00 HKT/SGT
OPPO Appoints Stagwell (STGW) Agencies in Singapore: Allison Worldwide for PR and Influencer; Assembly for Media  
Jan 15, 2026 14:00 HKT/SGT
Casa Minerals Inc. Announces Non-Brokered Private Placement Raising $800,000  
Jan 15, 2026 01:29 HKT/SGT
Doubleview Confirms Metal Recoveries for Upcoming Mineral Resource Estimate and Preliminary Economic Assessment  
Jan 14, 2026 21:59 HKT/SGT
Mitsubishi Power Lands Significant Gas Turbine Order for Qatar's Facility E IWPP Project  
Wednesday, January 14, 2026 5:58:00 PM
Mitsubishi Motors Launches Updated Outlander PHEV in Canada  
Wednesday, January 14, 2026 4:38:00 PM
SERES Lands on HKEX Today: Intelligence Redefines Luxury - The 'Tesla of China' Sets Sail for New Capital Blue Ocean  
Jan 14, 2026 14:30 HKT/SGT
GBA enterprises speed up ASEAN expansion, amid trade tensions, with 73 percent fast-tracking plans  
Jan 14, 2026 14:20 HKT/SGT
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: